Trial Profile
Impact of Ranalozine on Coronary Microcirculatory Resistance- A Prospective Single Center Study to Evaluate the Effect of Ranalozine in Microcirculatory Resistance (MICRO Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2023
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Coronary artery disease; Myocardial ischaemia
- Focus Pharmacodynamics
- Acronyms MICRO
- 07 Dec 2023 Status changed from recruiting to completed.
- 01 Apr 2013 New trial record